Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology

Feliciani, C; Joly, P; Jonkman, M F; Zambruno, G; Zillikens, D; Ioannides, D; Kowalewski, C; Jedlickova, H; Kárpáti, S; Marinovic, B; Mimouni, D; Uzun, S; Yayli, S; Hertl, M; Borradori, Luca (2015). Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. British journal of dermatology, 172(4), pp. 867-877. Wiley-Blackwell 10.1111/bjd.13717

Text bjd13717.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (122kB)

Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized or generalized bullous lesions. In up to 20% of affected patients, bullae may be completely absent, and only excoriations, prurigo-like lesions, eczematous lesions, urticated lesions and/or infiltrated plaques are observed. The disease is significantly associated with neurological disorders. The morbidity of bullous pemphigoid and its impact on quality of life are significant. So far, a limited number of national treatment guidelines have been proposed, but no common European consensus has emerged. Our consensus for the treatment of bullous pemphigoid has been developed under the guidance of the European Dermatology Forum in collaboration with the European Academy of Dermatology and Venereology. It summarizes evidence-based and expert-based recommendations.

Interest & Impact

Downloads

0 since deposited on 14 Mar 2016
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item